The weekly litigation news digest is live. Subscribe now

Esteve Pharmaceuticals competitive analysis

Loading summary...

Explore Esteve Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
Aug 4, 2021Oral Pharmaceutical Compositions Of Dabigatran Etexilate4

Latest PTAB cases involving Esteve Pharmaceuticals

Discover the latest PTAB cases involving Esteve Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Esteve Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ESTEVE PHARMACEUTICALS - 4 - -
AERA27 - - -
GLENMARK PHARMACEUTICALS EUROPE12 - - -
HAMM & WITTKOPP112 - - -